1] Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA [2] Department of Physiology, Shanxi Medical University, Taiyuan, China.
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
Neuropsychopharmacology. 2014 Mar;39(4):989-99. doi: 10.1038/npp.2013.299. Epub 2013 Oct 24.
Addictive drugs such as cocaine induce synaptic plasticity in discrete regions of the reward circuit. The aim of the present study is to investigate whether cocaine-evoked synaptic plasticity in the ventral tegmental area (VTA) and nucleus accumbens (NAc) is causally linked. Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is a central regulator of long-term synaptic plasticity, learning, and drug addiction. We examined whether blocking CaMKII activity in the VTA affected cocaine conditioned place preference (CPP) and cocaine-evoked synaptic plasticity in its target brain region, the NAc. TatCN21 is a CaMKII inhibitory peptide that blocks both stimulated and autonomous CaMKII activity with high selectivity. We report that intra-VTA microinjections of tatCN21 before cocaine conditioning blocked the acquisition of cocaine CPP, whereas intra-VTA microinjections of tatCN21 before saline conditioning did not significantly affect cocaine CPP, suggesting that the CaMKII inhibitor blocks cocaine CPP through selective disruption of cocaine-cue-associated learning. Intra-VTA tatCN21 before cocaine conditioning blocked cocaine-evoked depression of excitatory synaptic transmission in the shell of the NAc slices ex vivo. In contrast, intra-VTA microinjection of tatCN21 just before the CPP test did not affect the expression of cocaine CPP and cocaine-induced synaptic plasticity in the NAc shell. These results suggest that CaMKII activity in the VTA governs cocaine-evoked synaptic plasticity in the NAc during the time window of cocaine conditioning.
成瘾性药物,如可卡因,会在奖励回路的离散区域诱导突触可塑性。本研究旨在探讨腹侧被盖区(VTA)和伏隔核(NAc)中可卡因诱导的突触可塑性是否存在因果关系。钙/钙调蛋白依赖性蛋白激酶 II(CaMKII)是长时程突触可塑性、学习和药物成瘾的核心调节因子。我们研究了 VTA 中 CaMKII 活性的阻断是否会影响可卡因条件性位置偏爱(CPP)和可卡因在其靶脑区 NAc 中诱导的突触可塑性。TatCN21 是一种 CaMKII 抑制肽,对受刺激和自主 CaMKII 活性均具有高选择性。我们报告称,可卡因条件化前 VTA 内微量注射 TatCN21 可阻断可卡因 CPP 的获得,而可卡因条件化前 VTA 内微量注射 TatCN21 则不会显著影响可卡因 CPP,表明 CaMKII 抑制剂通过选择性破坏可卡因线索相关学习来阻断可卡因 CPP。可卡因条件化前 VTA 内 TatCN21 的微量注射可阻断可卡因诱导的 NAc 切片壳兴奋性突触传递的抑制。相比之下,CPP 测试前 VTA 内微量注射 TatCN21 并不影响 NAc 壳内可卡因 CPP 的表达和可卡因诱导的突触可塑性。这些结果表明,VTA 中的 CaMKII 活性在可卡因条件化的时间窗口内控制了 NAc 中可卡因诱导的突触可塑性。